Onychodystrophy
Onychodystrophy | |
ICD-10 | L60 |
---|---|
ICD-9 | 703.8 |
MedlinePlus | 003247 |
WikiDoc Resources for Onychodystrophy |
Articles |
---|
Most recent articles on Onychodystrophy Most cited articles on Onychodystrophy |
Media |
Powerpoint slides on Onychodystrophy |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Onychodystrophy at Clinical Trials.gov Trial results on Onychodystrophy Clinical Trials on Onychodystrophy at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Onychodystrophy NICE Guidance on Onychodystrophy
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Onychodystrophy Discussion groups on Onychodystrophy Patient Handouts on Onychodystrophy Directions to Hospitals Treating Onychodystrophy Risk calculators and risk factors for Onychodystrophy
|
Healthcare Provider Resources |
Causes & Risk Factors for Onychodystrophy |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Onychodystrophy is a deformation of the nails that can result from cancer chemotherapy which includes bleomycin, hydroxyurea, or 5-fluorouracil. It can include discoloration of the nail, or dyschromia.
Causes
Causes in Alphabetical Order
Diagnosis
Physical Examination
-
Hydroxyurea Nails; Nail changes associated with Hydroxyurea therapy in a patient with essential thrombocythemia